ADICON HOLDINGS (09860) has released its full-year results for the period ended December 31, 2025. During the reporting period, the Group recorded revenue of RMB 2.638 billion. Profit attributable to owners of the parent company was RMB 18.443 million, with basic earnings per share of RMB 0.03.

In terms of tendering, the company continued to enhance the systematic development of its bidding team. The total value of contracts won reached RMB 670 million, achieving a market opportunity coverage rate of 67% and a key customer retention rate of 91%. Concurrently, the number of contracts secured from public tertiary hospitals increased by 32% year-on-year, while the number from public secondary hospitals rose by 21%.

Looking ahead, the company plans to further refine its tender management processes, continuously improve market competitiveness, and fully seize high-quality business opportunities. Regarding the development of digital laboratories, the new-generation LIMS system has been implemented across all of its national laboratories, enabling full-process digital management of clinical labs. The PIMS system now covers 10 laboratories, achieving systematic management of the entire pathology workflow and quality control. The successful initial rollout of the new-generation NGS management system marks a significant breakthrough in the company's standardized development of specialized testing services.